📷 Image: Wikimedia Commons / Shariquejamalworld
Health
Fake Blood Pressure Tablets Seized from Gurugram Chemists, Probe Traces Source to Uttarakhand Factory
✍️ The Indian Express
🗓 28 Oct 2026, 09:36 AM
👁 20
Authorities in Gurugram confiscated counterfeit blood‑pressure tablets from several chemists and traced the supply chain back to a manufacturing unit in Uttarakhand.
Police in Gurugram conducted raids on multiple pharmacies after receiving complaints about ineffective blood‑pressure medication. During the operation, officials seized a batch of counterfeit tablets that were being sold as legitimate BP medicines.
Preliminary laboratory tests confirmed that the pills contained sub‑therapeutic or no active ingredients, posing a serious health risk to patients with hypertension. The investigation team then examined the distribution records and packaging, which pointed to a single source.
Tracing the supply chain led investigators to a clandestine manufacturing facility in Uttarakhand. The factory, reportedly operating without proper licensing, was producing the fake tablets for distribution across northern India. Law enforcement has now filed a case under the Drugs and Cosmetics Act and is coordinating with state health authorities for further action.
The incident underscores growing concerns over counterfeit medicines in the country and highlights the need for stricter monitoring of pharmaceutical supply chains.
Preliminary laboratory tests confirmed that the pills contained sub‑therapeutic or no active ingredients, posing a serious health risk to patients with hypertension. The investigation team then examined the distribution records and packaging, which pointed to a single source.
Tracing the supply chain led investigators to a clandestine manufacturing facility in Uttarakhand. The factory, reportedly operating without proper licensing, was producing the fake tablets for distribution across northern India. Law enforcement has now filed a case under the Drugs and Cosmetics Act and is coordinating with state health authorities for further action.
The incident underscores growing concerns over counterfeit medicines in the country and highlights the need for stricter monitoring of pharmaceutical supply chains.